Status: Recruiting
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
This is a double-blind, randomized, 12-week parallel study that aims to determine the effects of a cognitive nutritional supplement for 12 weeks on cognition parameters specific to attention/focus related domains, compared to a placebo control, in a general population of adult men and women in the United States.
Participants needed: 422
Trial details
Age: 25-65Biological sex: AllType: InterventionalSponsor: Pharmavite LLCUpdated: Apr 15, 2025Locations: 1
Eligibility criteria
Male or female, ≥25 to ≤65 years of age at screening. [+9]
Diagnosed neurological disorder such as Alzheimer's disease, Parkinson's disease... [+23]